- Home
- ALDX vs ACRE Comparison
ALDX vs ACRE Comparison
Compare ALDX & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALDX | ACRE |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.0M | 254.1M |
| IPO Year | 2014 | 2012 |
Fundamental Metrics
Financial Performance| Metric | ALDX | ACRE |
|---|---|---|
| Price | $5.25 | $5.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 5 |
| Target Price | ★ $9.50 | $5.33 |
| AVG Volume (30 Days) | ★ 1.5M | 482.0K |
| Earning Date | 11-05-2025 | 11-07-2025 |
| Dividend Yield | N/A | ★ 11.21% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $87,777,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $36.25 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 122.65 |
| 52 Week Low | $1.14 | $3.35 |
| 52 Week High | $7.20 | $6.83 |
Technical Indicators
Market Signals| Indicator | ALDX | ACRE |
|---|---|---|
| Relative Strength Index (RSI) | 54.68 | 61.59 |
| Support Level | $3.94 | $5.25 |
| Resistance Level | $4.91 | $5.55 |
| Average True Range (ATR) | 0.41 | 0.14 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 75.22 | 57.55 |
Price Performance
Historical ComparisonAbout ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.